Tyrosine kinase inhibitors
Sponsors
GlaxoSmithKline, Tang-Du Hospital
Conditions
CancerNon-small Cell Lung Cancer Metastatic
Unknown Phase
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
CompletedNCT01098500
Start: 2009-02-28End: 2010-10-31Updated: 2017-05-30
A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
NCT03424980
Start: 2017-12-31End: 2018-04-30Target: 200Updated: 2018-02-08